OMUFA - Screening Non-Sterile OTC Monograph Products for Microbial Contamination
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- Christopher Scott christopher.scott@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is seeking a research and development study focused on evaluating non-sterile, aqueous-based over-the-counter (OTC) monograph drugs for microbial contamination. This research aims to enhance the FDA's surveillance of OTC monograph products and potentially reduce adverse events associated with these medications. The estimated solicitation release date is July 1, 2026, with an anticipated contract award date of September 1, 2026.
The contract falls under the NAICS category 541714 for Research and Development in Biotechnology, with no specific set-aside designation. The primary point of contact for this opportunity is Christopher Scott, who can be reached at christopher.scott@fda.hhs.gov within the Food and Drug Administration. While specific award values, precise performance locations, and detailed contract specifics are not currently available, interested contractors should focus on biotechnology research capabilities and expertise in microbial contamination screening for pharmaceutical products.
Forecast text
OMUFA - A study will be designed to evaluate non-sterile, aqueous based, OTC monographdrugs for microbial contamination. This will enhance FDA's surveillance of OTC monograph products andpotentially reduce the incidence of adverse events.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast